Recent breakthroughs in the field of diabetes treatment have introduced a new class of medications known as GLP-1 receptor agonists. These agents work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a https://anitaemvp860507.bloggerchest.com/40559024/novel-glp-1-receptor-agonists-semaglutide-tirzepatide-and-retatrutide